Annual Revenue:
$57.88M+$21.60M(+59.55%)Summary
- As of today, NTLA annual revenue is $57.88 million, with the most recent change of +$21.60 million (+59.55%) on December 31, 2024.
- During the last 3 years, NTLA annual revenue has risen by +$24.82 million (+75.10%).
- NTLA annual revenue is now -0.20% below its all-time high of $57.99 million, reached on December 31, 2020.
Performance
NTLA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$13.78M-$463.00K(-3.25%)Summary
- As of today, NTLA quarterly revenue is $13.78 million, with the most recent change of -$463.00 thousand (-3.25%) on September 30, 2025.
- Over the past year, NTLA quarterly revenue has increased by +$4.67 million (+51.27%).
- NTLA quarterly revenue is now -52.37% below its all-time high of $28.93 million, reached on March 31, 2024.
Performance
NTLA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$57.53M+$4.67M(+8.84%)Summary
- As of today, NTLA TTM revenue is $57.53 million, with the most recent change of +$4.67 million (+8.84%) on September 30, 2025.
- Over the past year, NTLA TTM revenue has increased by +$14.44 million (+33.52%).
- NTLA TTM revenue is now -7.71% below its all-time high of $62.34 million, reached on September 30, 2020.
Performance
NTLA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NTLA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +59.5% | +51.3% | +33.5% |
| 3Y3 Years | +75.1% | +3.9% | +11.9% |
| 5Y5 Years | +34.3% | -38.0% | -7.7% |
NTLA Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +75.1% | -52.4% | +818.9% | -0.6% | +58.6% |
| 5Y | 5-Year | -0.2% | +75.1% | -52.4% | +818.9% | -7.7% | +114.7% |
| All-Time | All-Time | -0.2% | >+9999.0% | -52.4% | +818.9% | -7.7% | +4373.4% |
NTLA Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $13.78M(-3.3%) | $57.53M(+8.8%) |
| Jun 2025 | - | $14.24M(-14.3%) | $52.86M(+16.0%) |
| Mar 2025 | - | $16.63M(+29.2%) | $45.57M(-21.3%) |
| Dec 2024 | $57.88M(+59.6%) | $12.87M(+41.3%) | $57.88M(+34.3%) |
| Sep 2024 | - | $9.11M(+31.0%) | $43.09M(-6.3%) |
| Jun 2024 | - | $6.96M(-76.0%) | $45.97M(-12.6%) |
| Mar 2024 | - | $28.93M(+1609.4%) | $52.60M(+45.0%) |
| Dec 2023 | $36.27M(-30.4%) | -$1.92M(-116.0%) | $36.27M(-29.9%) |
| Sep 2023 | - | $11.99M(-11.8%) | $51.77M(-2.4%) |
| Jun 2023 | - | $13.59M(+7.8%) | $53.04M(-0.8%) |
| Mar 2023 | - | $12.61M(-7.1%) | $53.48M(+2.6%) |
| Dec 2022 | $52.12M(+57.7%) | $13.57M(+2.3%) | $52.12M(+1.4%) |
| Sep 2022 | - | $13.27M(-5.4%) | $51.40M(+13.4%) |
| Jun 2022 | - | $14.03M(+24.7%) | $45.34M(+19.8%) |
| Mar 2022 | - | $11.25M(-12.5%) | $37.86M(+14.5%) |
| Dec 2021 | $33.05M(-43.0%) | $12.85M(+78.4%) | $33.05M(+23.4%) |
| Sep 2021 | - | $7.20M(+10.0%) | $26.79M(-35.9%) |
| Jun 2021 | - | $6.55M(+1.6%) | $41.81M(-18.9%) |
| Mar 2021 | - | $6.45M(-2.3%) | $51.52M(-11.2%) |
| Dec 2020 | $57.99M | $6.59M(-70.3%) | $57.99M(-7.0%) |
| Sep 2020 | - | $22.22M(+36.6%) | $62.34M(+22.9%) |
| Jun 2020 | - | $16.26M(+25.9%) | $50.73M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $12.92M(+18.1%) | $45.59M(+5.8%) |
| Dec 2019 | $43.10M(+41.6%) | $10.94M(+3.0%) | $43.10M(+7.6%) |
| Sep 2019 | - | $10.62M(-4.5%) | $40.05M(+8.7%) |
| Jun 2019 | - | $11.12M(+6.6%) | $36.84M(+10.3%) |
| Mar 2019 | - | $10.43M(+32.4%) | $33.40M(+9.7%) |
| Dec 2018 | $30.43M(+16.5%) | $7.88M(+6.4%) | $30.43M(+4.1%) |
| Sep 2018 | - | $7.41M(-3.5%) | $29.22M(+0.3%) |
| Jun 2018 | - | $7.68M(+2.8%) | $29.13M(+6.4%) |
| Mar 2018 | - | $7.47M(+12.0%) | $27.37M(+4.8%) |
| Dec 2017 | $26.12M(+58.5%) | $6.67M(-8.9%) | $26.12M(+4.2%) |
| Sep 2017 | - | $7.32M(+23.7%) | $25.08M(+10.8%) |
| Jun 2017 | - | $5.92M(-4.8%) | $22.63M(+8.2%) |
| Mar 2017 | - | $6.21M(+10.4%) | $20.92M(+26.9%) |
| Dec 2016 | $16.48M(+172.7%) | $5.63M(+15.6%) | $16.48M(+31.4%) |
| Sep 2016 | - | $4.87M(+15.8%) | $12.54M(+34.0%) |
| Jun 2016 | - | $4.21M(+136.7%) | $9.36M(+43.3%) |
| Mar 2016 | - | $1.78M(+5.0%) | $6.54M(+8.1%) |
| Dec 2015 | $6.04M(>+9900.0%) | $1.69M(+0.3%) | $6.04M(+38.9%) |
| Sep 2015 | - | $1.69M(+22.6%) | $4.35M(+63.4%) |
| Jun 2015 | - | $1.38M(+7.1%) | $2.66M(+107.1%) |
| Mar 2015 | - | $1.29M | $1.29M |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is Intellia Therapeutics, Inc. annual revenue?
- What is the all-time high annual revenue for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual revenue year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly revenue?
- What is the all-time high quarterly revenue for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Intellia Therapeutics, Inc. TTM revenue?
- What is the all-time high TTM revenue for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM revenue year-on-year change?
What is Intellia Therapeutics, Inc. annual revenue?
The current annual revenue of NTLA is $57.88M
What is the all-time high annual revenue for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual revenue is $57.99M
What is Intellia Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, NTLA annual revenue has changed by +$21.60M (+59.55%)
What is Intellia Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of NTLA is $13.78M
What is the all-time high quarterly revenue for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly revenue is $28.93M
What is Intellia Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, NTLA quarterly revenue has changed by +$4.67M (+51.27%)
What is Intellia Therapeutics, Inc. TTM revenue?
The current TTM revenue of NTLA is $57.53M
What is the all-time high TTM revenue for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM revenue is $62.34M
What is Intellia Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, NTLA TTM revenue has changed by +$14.44M (+33.52%)